近日，作为北京市"三个100"重点工程，由中建一局参建的北京京东方生命科技产业基地举行开园仪式并启动发布会。北京市房山区政府相关领导、京东方 集团高管、中建一局相关人员等出席仪式。该基地建设是服务国家医工融合创新与京津冀协同发展的核心载体，为京津冀健康产业协同发展注入强劲新动 力。 京东方生命科技产业基地由智慧医工核心能力中心及北京京东方医院构成，聚焦生命科技与智慧健康，致力于构建"医教研产用"健康创新生态。其中，北京 京东方生命科技产业基地健康云算力中心项目，是基地的核心组成部分。建成后将为构建全球一流的"医教研产用"健康创新生态提供强大算力保障，对提升 市场核心竞争力将产生深远影响。 在建设过程中，项目团队成功攻克多项技术难题。面对数据中心管综排布与层高受限双重挑战，项目团队在全周期建设中创新应用BIM技术，模型深度达到 LOD400零件级精度，精确定位阀门手柄的布设方位，细致核查地板支腿与管线的碰撞隐患，成功突破层高瓶颈，成为数据中心管综排布新标杆，为高质量 建设提供技术支撑和可视化保障。 同时，项目团队针对原设计方案中屋面设备基础直接设置于保护层上可能引发的沉降风险，首创架空式管道钢结构集成平台，不仅 ...

2025年9月25日， 第二届医疗器械研发论坛 在 Medtec 2025 国际医疗器械设计与制造技术展览会 现场圆满举办。本次论坛由思宇MedTech组织，获得展会主办 方 英富曼集团 的大力支持。作为聚焦研发与制造的专业平台，Medtec 已经在中国成功举办19届，见证了中国医疗器械产业的成长与国际化。 赵清，思宇MedTech创始人，在论坛开场时表示："Medtec的特别之处在于它聚焦医疗器械的'源头'环节。这里不仅是展示窗口，更是推动行业交流与创新的加速 器。" # 开幕致辞：见证21年的医疗器械产业成长 顾晓媛，英富曼会展集团医疗健康&IP授权 总经理 顾总在致辞中强调，Medtec China 作为Medtech全球系列展的重要一站，已陪伴中国医疗器械产业二十余年， 是产业的加速器。展会与论坛的结合，正是促进产业交流与国际合作的关键形式。 # 医工融合与转化：医院与研发的连接 雷娟，四川西部医药技术转移中心 理事长/主任，中国医学装备协会医疗器械创新与应用分会 副会长 雷娟分享了华西医院的科技成果转化历程，医院不仅是临床 验证的场所，更是科技成果转化的源头。通过建立多学科交叉平台和成果转化机制，越 ...

中新网广州9月21日电 (记者 王坚)作为2025年岭南科技创新论坛平行论坛之一，"新质生产力赋能医疗 器械前沿科技与成果转化论坛"(下称"成果转化论坛")20日至21日在广州举行。该论坛面向全国高性能医 疗器械科技创新发展与产学研深度融合发展需求，探讨医工融合与新质生产力赋能背景下高性能医疗器 械领域的最新进展。 目前，我国在医疗器械产业领域，初步建立了完善的产业发展生态链，国产化水平持续向好，国内企业 数量不断增加，产品输出力持续增强。 成果转化论坛上，与会专家学者在专题报告中提到，目前，目前我国创新和高性能医疗研发正步入快车 道，人工智能医疗器械发展非常迅猛。2024年获批的人工智能三类医疗器械产品，直接应用的AI技术 约占1/3。其中，医学影像AI医疗器械获批最多。 论坛现场。广东省科协 供图 其中，清华大学长聘教授、生物医学工程学院执行院长王广志作了"智能化医疗器械创新发展与挑战"专 题报告，剖析了智能化医疗器械的技术瓶颈与突破方向。他认为，AI的快速发展，给高端医疗器械创 新带来了巨大机遇和发展动力。为了更好地发挥智能化医疗器械的潜力，突破现有诊疗路径的瓶颈和禁 区，推动临床多层级的研发应用，需要 ...

Core Viewpoint - Guangdong Province leads the innovation in the medical device industry with 8,200 research and production enterprises, reflecting the rapid development of high-performance medical device technology in China [1][4]. Group 1: Industry Overview - The forum held in Guangzhou focused on the integration of medical and engineering fields, discussing the latest advancements and challenges in high-performance medical devices amid complex international circumstances [1]. - By 2030, one-sixth of the global population will be over 60 years old, with China expected to have 310 million people aged 60 and above by the end of 2024, indicating a growing demand for diverse and high-quality medical devices [2][3]. Group 2: Market Dynamics - The domestic market for medical devices has seen a significant shift, with foreign companies' market share decreasing from over 90% in 2015 to 65% in 2023, highlighting the increasing competitiveness of domestic enterprises [3]. - The number of domestic medical device manufacturers has surged from 16,356 in 2018 to 34,635 by mid-2023, marking an increase of 111.8% [3]. Group 3: Technological Advancements - The development of artificial intelligence in medical devices is accelerating, with approximately one-third of AI-based medical devices approved in 2024 directly applying AI technology, particularly in medical imaging [3]. Group 4: Strategic Recommendations - Guangdong Province is encouraged to enhance scientific and technological innovation, improve talent cultivation in the medical device sector, and optimize the development ecosystem for the industry [4].

Core Insights - The launch of the BOE Life Science Technology Industrial Base marks its official opening and full operation, serving as a key project in Beijing's "Three Hundreds" initiative [1] - The base is a core carrier for BOE Group's "Screen-Internet of Things" strategy, supporting national medical-engineering integration innovation and the coordinated development of Beijing-Tianjin-Hebei [1] - The facility aims to create a world-class health innovation ecosystem by integrating medical and engineering technologies, focusing on life sciences and smart health [1] Company Developments - The BOE Life Science Technology Industrial Base consists of a Smart Medical Engineering Core Competence Center and Beijing BOE Hospital, emphasizing medical-engineering integration [1] - The base will establish the first medical device CDMO and testing platform in Fangshan, with the first phase GMP laboratory already operational, addressing the lack of medical device industrialization platforms in the southwestern Beijing area [1] - The base will provide comprehensive services including technical R&D support, achievement transformation incubation, industry resource connection, and market promotion empowerment to foster innovation and industry cluster development [1] Strategic Partnerships - During the launch event, BOE Life Science Technology Industrial Base reached a cooperation intention with GE Healthcare, focusing on the development of high-end medical equipment [1] - The collaboration aims to promote the intelligent upgrade and domestic innovation process of China's medical equipment [1]

Core Viewpoint - The opening of the BOE Life Science Technology Industrial Base in Fangshan District is a significant step towards enhancing the capital's new productivity and promoting the collaborative development of the health industry in the Beijing-Tianjin-Hebei region [1][3]. Group 1: Industrial Base Overview - The BOE Life Science Technology Industrial Base consists of a Smart Medical Engineering Core Competence Center and Beijing BOE Hospital, focusing on the integration of medical and engineering fields [1][3]. - The base aims to create a comprehensive innovation ecosystem that spans the entire industry chain from research and development to application promotion in life science and smart health [1][3]. Group 2: Services and Collaborations - The industrial base will provide full-chain services including technical research and development support, achievement transformation incubation, industrial resource docking, and market promotion empowerment to foster innovation and cultivate industrial clusters [3]. - A collaboration intention has been established with GE Healthcare to focus on the research and development of high-end medical equipment, promoting the intelligent upgrade and domestic innovation of China's medical equipment [3]. Group 3: Hospital Development - The Beijing BOE Hospital, a key component of the innovation ecosystem, has completed the main structure topping and is designed to have a total of 1,500 beds, with the first phase construction accommodating 1,000 beds [3]. - The hospital will emphasize the transformation and application of advanced diagnostic and treatment technologies in oncology, critical care, and rehabilitation, while also participating in the construction of a close-knit medical alliance in Fangshan [3]. Group 4: Existing Infrastructure and Achievements - Over 12 years, BOE Health has developed a smart medical service system centered on health management, supported by medical engineering products, digital hospitals, and smart health care [4]. - BOE has established five digital hospitals across Beijing, Hefei, Chengdu, and Suzhou, with a total of over 5,600 beds and thousands of medical experts, serving over 4 million clients [4].

Group 1 - The launch of the BOE Life Science Technology Industrial Base in Beijing marks its official opening and operational commencement, alongside the completion of the main structure of Beijing BOE Hospital [1] - The industrial base is a key project under Beijing's "Three Hundreds" initiative, aimed at supporting national medical-engineering integration and the coordinated development of the Beijing-Tianjin-Hebei region [1] - The base consists of a core capability center for smart medical engineering and Beijing BOE Hospital, focusing on life sciences and smart health, facilitating the entire industry chain from R&D to application [1] Group 2 - Beijing BOE Hospital is a critical component of the innovation ecosystem, designed as a smart IoT hospital with a planned total of 1,500 beds, with the first phase accommodating 1,000 beds [3] - The hospital aims to leverage advanced treatment technologies in oncology, critical care, and rehabilitation, while establishing a digital twin hospital platform [3] - BOE has developed a smart medical service system over 12 years, with five digital hospitals across major cities, totaling over 5,600 beds and serving over 4 million patients [3]

Core Insights - The 2025 Service Trade Fair in Beijing showcased innovative healthcare solutions, including AI-assisted self-diagnosis rooms and wearable devices for real-time health monitoring, highlighting the integration of technology in healthcare [2] Group 1: AI and Traditional Medicine Integration - The China Academy of Chinese Medical Sciences demonstrated a small-scale meridian conditioning robot for treating tension-type headaches, emphasizing the stability and effectiveness of machine-assisted treatments over manual methods [3] - The "AI consultation" platform, powered by a large model, offers a comprehensive self-service experience from triage to follow-up, showcasing the potential of AI in traditional Chinese medicine [3][5] Group 2: Surgical Robotics and AI Applications - Advanced surgical robots, including a microwave water knife and AI catheter shaping robots, were introduced, addressing common challenges in minimally invasive surgeries and enhancing precision in tumor removal [6] - An AI visual monitoring system for critical care was presented, capable of real-time patient monitoring and early warning for adverse events, demonstrating the growing role of AI in patient safety and decision-making [6][8] Group 3: Pediatric Health Innovations - The fair highlighted intelligent solutions for children's health, such as a smart fundus camera that aids in eye health screenings for young children, improving access to quality care [9] - A companion robot designed for children with high-functioning autism provides interactive assessments and training, supporting early diagnosis and rehabilitation efforts [11]

Core Insights - The report published by The British Medical Journal highlights the significant impact of Chinese hospitals on global medical research and public health decision-making from 2005 to 2024, with over 12,000 articles cited in health policy and clinical guidelines across more than 75 countries, totaling nearly 35,000 citations [1][3] Group 1: Research Impact - The report emphasizes the increasing role of Chinese medical research in shaping international medical standards, enhancing healthcare supply, and improving patient treatment outcomes [3] - The top ten Chinese hospitals with the most cited articles include Sichuan University West China Hospital, Peking Union Medical College Hospital, Sun Yat-sen University First Affiliated Hospital, and Peking University First Hospital [3] Group 2: High-Quality Research Contributions - Chinese hospitals are progressively producing high-quality research that contributes significantly to global medical advancements, particularly in oncology, cardiology, and infectious diseases [5] - The "Beijing Plan" for haploidentical stem cell transplantation, developed by a Chinese academic, has provided hope for blood cancer patients globally [5] Group 3: Integration of Traditional and Modern Medicine - The integration of traditional Chinese medicine with modern technology is being showcased, with efforts to clarify the mechanisms of traditional remedies [6] - The development of innovative drugs, such as the anti-respiratory syncytial virus drug, demonstrates China's commitment to pediatric drug research [6] Group 4: Future Medical Innovations - The 2025 Service Trade Fair highlighted advancements in medical technology, including AI pediatricians and brain-machine interfaces, indicating a shift towards more sophisticated medical systems [8] - A groundbreaking clinical exploration of a brain-machine interface for treating spinal cord injuries was completed, showcasing China's innovative capabilities in medical research [8] Group 5: Global Collaboration and Health Goals - The Chinese government is committed to advancing medical technology research to address global health challenges and promote international collaboration [9]

Core Insights - The report highlights the significant impact of Chinese medical research on global health, with over 12,000 articles cited in health policy and clinical guidelines across more than 75 countries from 2005 to 2024 [1][2] - Chinese hospitals are increasingly producing high-quality research, particularly in oncology, cardiology, and infectious diseases, contributing to global medical advancements [3][6] Group 1: Research Impact - The report from The British Medical Journal indicates that the top ten Chinese hospitals have had their research cited nearly 35,000 times in global health policies and clinical guidelines [1][2] - Notable hospitals include Sichuan University West China Hospital, Peking Union Medical College Hospital, and Sun Yat-sen University First Affiliated Hospital, showcasing the growing visibility of Chinese medical research [2] Group 2: Innovations and Contributions - Chinese researchers are addressing global health challenges, such as the "Beijing Protocol" for haploidentical stem cell transplantation, which has provided hope for blood cancer patients [3] - The integration of traditional Chinese medicine with modern technology is being emphasized, with efforts to clarify the mechanisms of traditional remedies [3] Group 3: Future of Medical Research - China ranks second globally in the number of new drugs under development, accounting for over 20% of the total [5] - Innovations such as brain-machine interfaces and AI-driven medical solutions are being showcased, indicating a shift towards more advanced and specialized medical technologies [5][6]